News | July 07, 2025
SPARC incorporates subsidiary ‘Genokine Biotech’
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
The change of name has been carried on pursuant to the Scheme of Amalgamation
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The National IP Awards recognize outstanding contributions to India’s innovation economy through effective IP creation and commercialization
Announces Rs. 317 crore investment in new recycling plant
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Subscribe To Our Newsletter & Stay Updated
